ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
Dyadic and Rubic to develop Covid-19 vaccines for African markets pharmaceutical-technology
July 28, 2021Dyadic International has entered a Covid-19 vaccine technology transfer and licensing agreement with South Africa-based company, Rubic Consortium, to discover, develop, analyse and produce cost-efficient vaccines for supply mainly to the African markets.
Pharma Sources Insight January 2025
